Issue

FDMSEC Insights 02 - Biosimilars, Generics and Brand Confusion

This issue clarifies biosimilars, tender drugs, and market brands, with practical guidance on medicine storage, handling, traceability, and consistent implementation of regulatory requirements in clinical practice.